rs4149056 · Pharmacogenomics
SLCO1B1 determines how you metabolize statin medications. The wrong statin at the wrong dose for your genotype can cause severe muscle pain (myopathy).
SLCO1B1 encodes a hepatic transporter that clears statins from the blood into the liver. The C allele reduces transport efficiency, causing higher blood levels of certain statins (especially simvastatin). This dramatically increases the risk of myopathy — from ~1-5% baseline to up to 60% for simvastatin 80mg in CC carriers. FDA labeling for simvastatin now references this pharmacogenomic interaction.
| Genotype | Status | What It Means |
|---|---|---|
| TT | Normal | Standard statin metabolism. No genotype-based dose restriction. |
| TC | Intermediate | ~4x increased myopathy risk with simvastatin. Consider dose reduction or alternative statin. |
| CC | Poor transporter | ~17x increased myopathy risk with simvastatin. Use rosuvastatin or pravastatin instead. |
If you take statins and carry the C allele, discuss alternatives with your doctor. Rosuvastatin and pravastatin are less affected by SLCO1B1. Never stop statins without medical advice — the cardiovascular benefits may outweigh the myopathy risk.
This is just 1 of 200+ SNPs we analyze. Get your complete health report with ClinVar disease risk, drug interactions, and a personalized protocol.
Get Report — $29This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare provider before making health decisions based on genetic data. Genome Decoder does not diagnose, treat, or prevent any disease.